• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[이데일리] 국내 최초 CAR-T 치료제 탄생 앞둔 김건수 큐로셀 대표[화제의 바이오人]

2023/10/29

국내 최초 CAR-T 치료제 탄생 앞둔 김건수 큐로셀 대표[화제의 바이오人] (edaily.co.kr)

이데일리 김세미 기자

Prev큐로셀, 차세대 CAR-T 임상2상 완료 “국내 최초 사례”
Next큐로셀, 청약 경쟁률 170대 1 기록…11월 9일 상장
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.